How much revenue did Nutex Befektetesi Nyrt generate this year?
Nutex Befektetesi Nyrt has achieved a revenue of 450,000 HUF this year.
In 2024, Nutex Befektetesi Nyrt's sales reached 450,000 HUF, a 0% difference from the 450,000 HUF sales recorded in the previous year.
YEAR | REVENUE (undefined HUF) | GROSS MARGIN (%) |
---|---|---|
2022 | 0 | 177,78 |
2021 | 0 | 177,78 |
2020 | 0 | 160,00 |
2019 | 0 | 100,00 |
2018 | 0 | 100,00 |
2017 | 0.01 | 100,00 |
2016 | 0.13 | 1,83 |
2015 | 0.01 | 27,27 |
2014 | 1.02 | 50,29 |
2013 | 1.14 | 45,34 |
2012 | 1.22 | 49,71 |
2011 | 1.76 | 44,13 |
2010 | 1.3 | 48,68 |
2009 | 0.81 | 51,47 |
2008 | 2.23 | 43,01 |
2007 | 0.73 | 64,37 |
2006 | 0.13 | 52,48 |
2005 | 0.06 | 16,01 |
2004 | 0.1 | 73,27 |
2003 | 0.17 | 0,29 |
The sales figures of Nutex Befektetesi Nyrt originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Analyzing Nutex Befektetesi Nyrt’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Investors often scrutinize Nutex Befektetesi Nyrt's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Increases in Nutex Befektetesi Nyrt’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Nutex Befektetesi Nyrt has achieved a revenue of 450,000 HUF this year.
The revenue of Nutex Befektetesi Nyrt has increased by 0% increased compared to the previous year.
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
The revenue of Nutex Befektetesi Nyrt is influenced by various factors, including the demand for its products and services, market conditions, and prices.
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
The revenue of Nutex Befektetesi Nyrt is an important indicator of financial performance and attractiveness for investors.
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
Over the past 12 months, Nutex Befektetesi Nyrt paid a dividend of 10 HUF . This corresponds to a dividend yield of about 68.73 %. For the coming 12 months, Nutex Befektetesi Nyrt is expected to pay a dividend of 0 HUF.
The current dividend yield of Nutex Befektetesi Nyrt is 68.73 %.
Nutex Befektetesi Nyrt pays a quarterly dividend. This is distributed in the months of .
Nutex Befektetesi Nyrt paid dividends every year for the past 0 years.
For the upcoming 12 months, dividends amounting to 0 HUF are expected. This corresponds to a dividend yield of 0 %.
Nutex Befektetesi Nyrt is assigned to the 'Health' sector.
To receive the latest dividend of Nutex Befektetesi Nyrt from 6/15/2011 amounting to 10 HUF, you needed to have the stock in your portfolio before the ex-date on 6/3/2011.
The last dividend was paid out on 6/15/2011.
In the year 2023, Nutex Befektetesi Nyrt distributed 0 HUF as dividends.
The dividends of Nutex Befektetesi Nyrt are distributed in HUF.
Our stock analysis for Nutex Befektetesi Nyrt Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nutex Befektetesi Nyrt Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.